80 related articles for article (PubMed ID: 10450371)
1. Assessment of the Heidelberg Retina Tomograph in the detection of sight-threatening diabetic maculopathy.
Zambarakji HJ; Butler TK; Vernon SA
Eye (Lond); 1999 Apr; 13 ( Pt 2)():136-44. PubMed ID: 10450371
[TBL] [Abstract][Full Text] [Related]
2. Volumetric analysis of early macular edema with the Heidelberg Retina Tomograph in diabetic retinopathy.
Zambarakji HJ; Amoaku WM; Vernon SA
Ophthalmology; 1998 Jun; 105(6):1051-9. PubMed ID: 9627656
[TBL] [Abstract][Full Text] [Related]
3. Frequency-doubled Nd:YAG laser for the treatment of exudative diabetic maculopathy.
Saeed M; Parmar D; McHugh D
Eye (Lond); 2001 Dec; 15(Pt 6):712-8. PubMed ID: 11826988
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of a new scoring system for diabetic macular oedema detection using a confocal laser imaging system.
Tong L; Ang A; Vernon SA; Zambarakji HJ; Bhan A; Sung V; Page S
Br J Ophthalmol; 2001 Jan; 85(1):34-9. PubMed ID: 11133709
[TBL] [Abstract][Full Text] [Related]
5. Identification of diabetic macular oedema using retinal thickness measurements.
Knudsen LL
Acta Ophthalmol Scand; 2007 Feb; 85(1):27-31. PubMed ID: 17244206
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
Margolis R; Singh RP; Bhatnagar P; Kaiser PK
Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
[TBL] [Abstract][Full Text] [Related]
7. Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.
Scanlon PH; Foy C; Chen FK
Br J Ophthalmol; 2008 Jun; 92(6):775-8. PubMed ID: 18356262
[TBL] [Abstract][Full Text] [Related]
8. Clinical applications of the MicroPulse diode laser.
Moorman CM; Hamilton AM
Eye (Lond); 1999 Apr; 13 ( Pt 2)():145-50. PubMed ID: 10450372
[TBL] [Abstract][Full Text] [Related]
9. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
Wilczyński M; Dzivgielewski K
Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
[TBL] [Abstract][Full Text] [Related]
10. Validity of screening for glaucomatous optic nerve damage using confocal scanning laser ophthalmoscopy (Heidelberg Retina Tomograph II) in high-risk populations: a pilot study.
Harasymowycz PJ; Papamatheakis DG; Fansi AK; Gresset J; Lesk MR
Ophthalmology; 2005 Dec; 112(12):2164-71. PubMed ID: 16325710
[TBL] [Abstract][Full Text] [Related]
11. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
Kristinsson JK
Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
[TBL] [Abstract][Full Text] [Related]
12. Association of systemic health and functional outcomes with changes in hard exudates associated with clinically significant macular oedema over the natural course of the disease.
Kameda Y; Kumakawa M; Endo N; Iwamoto Y; Kitano S
Br J Ophthalmol; 2010 Jun; 94(6):725-9. PubMed ID: 20508046
[TBL] [Abstract][Full Text] [Related]
13. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.
Vujosevic S; Midena E; Pilotto E; Radin PP; Chiesa L; Cavarzeran F
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3044-51. PubMed ID: 16799051
[TBL] [Abstract][Full Text] [Related]
14. Retinal thickness study with optical coherence tomography in patients with diabetes.
Sánchez-Tocino H; Alvarez-Vidal A; Maldonado MJ; Moreno-Montañés J; García-Layana A
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1588-94. PubMed ID: 11980878
[TBL] [Abstract][Full Text] [Related]
15. Influence of laser photocoagulation for clinically significant diabetic macular oedema (DMO) on short-wavelength and conventional automated perimetry.
Hudson C; Flanagan JG; Turner GS; Chen HC; Young LB; McLeod D
Diabetologia; 1998 Nov; 41(11):1283-92. PubMed ID: 9833934
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
Soliman W; Sander B; Soliman KA; Yehya S; Rahamn MS; Larsen M
Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
[TBL] [Abstract][Full Text] [Related]
17. Retinal thickness variation in the diabetic patient measured by the retinal thickness analyser.
Weinberger D; Axer-Siegel R; Landau D; Yassur Y
Br J Ophthalmol; 1998 Sep; 82(9):1003-6. PubMed ID: 9893588
[TBL] [Abstract][Full Text] [Related]
18. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes.
Byeon SH; Chu YK; Lee H; Lee SY; Kwon OW
Ophthalmology; 2009 Oct; 116(10):1949-59.e8. PubMed ID: 19699533
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study.
Broadbent DM; Scott JA; Vora JP; Harding SP
Eye (Lond); 1999 Apr; 13 ( Pt 2)():160-5. PubMed ID: 10450374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
